Abbott Pulls Bioresorbable Vascular Scaffold From European Market As FDA Investigates Blood Clot Risks
Abbott Laboratories is pulling its BVS dissolving stent from markets in Europe, but leaving them for sale in the U.S., as concerns grow over blood clots and heart attacks linked…